Evidence map›Paper›PMID 26029103›Full record

ReviewFrontiers in aging neuroscience2015

Synergistic effects of free radical scavengers and cochlear vasodilators: a new otoprotective strategy for age-related hearing loss.

Juan Carlos Alvarado, Verónica Fuentes-Santamaría, Pedro Melgar-Rojas, María Llanos Valero, María Cruz Gabaldón-Ull, Josef M Miller, José M Juiz

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Review
  3. The crossroads between osteosarcopenia and intrinsic capacity-a narrative review.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Redox homeostasis dysregulation in noise-induced hearing loss: oxidative stress and antioxidant treatment.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale · 2023
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Juan Carlos AlvaradoFacultad de Medicina, Universidad de Castilla-La Mancha, Instituto de Investigación en Discapacidades Neurológicas (IDINE) Albacete, Spain.
Verónica Fuentes-SantamaríaFacultad de Medicina, Universidad de Castilla-La Mancha, Instituto de Investigación en Discapacidades Neurológicas (IDINE) Albacete, Spain.
Pedro Melgar-RojasFacultad de Medicina, Universidad de Castilla-La Mancha, Instituto de Investigación en Discapacidades Neurológicas (IDINE) Albacete, Spain.
María Llanos ValeroFacultad de Medicina, Universidad de Castilla-La Mancha, Instituto de Investigación en Discapacidades Neurológicas (IDINE) Albacete, Spain.
María Cruz Gabaldón-UllFacultad de Medicina, Universidad de Castilla-La Mancha, Instituto de Investigación en Discapacidades Neurológicas (IDINE) Albacete, Spain.
Josef M MillerKarolinska Institutet Stockholm, Sweden ; Kresge Hearing Research Institute, University of Michigan Ann Arbor, MI, USA.
José M JuizFacultad de Medicina, Universidad de Castilla-La Mancha, Instituto de Investigación en Discapacidades Neurológicas (IDINE) Albacete, Spain.
University of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing increase in age-related hearing loss (ARHL), with its dramatic reduction in quality of life and significant increase in health care costs, is a catalyst to develop new therapeutic strategies to prevent or reduce this aging-associated condition. In this regard, there is extensive evidence that excessive free radical formation along with diminished cochlear blood flow are essential factors involved in mechanisms of other stress-related hearing loss, such as that associated with noise or ototoxic drug exposure. The emerging view is that both play key roles in ARHL pathogenesis. Therapeutic targeting of excessive free radical formation and cochlear blood flow regulation may be a useful strategy to prevent onset of ARHL. Supporting this idea, micronutrient-based therapies, in particular those combining antioxidants and vasodilators like magnesium (Mg(2+)), have proven effective in reducing the impact of noise and ototoxic drugs in the inner ear, therefore improving auditory function. In this review, the synergistic effects of combinations of antioxidant free radicals scavengers and cochlear vasodilators will be discussed as a feasible therapeutic approach for the treatment of ARHL.

Indexed as

antioxidantscochlear blood flowmagnesiumoxidative stresspresbyacusissensorineural hearing lossvitamins

Identifiers

PMID26029103
PMCPMC4432684
OpenAlexW1585823418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.